Chinese-language VISs
Out-of-date

The translations for some VISs on our website are from previously published English-language versions that have since been updated. Unfortunately, IAC is not always able to obtain translations as updates are issued. Please ensure that your patients receive information consistent with the current English-language version of the following VISs.

You are encouraged to distribute the up-to-date English-language VIS at the same time as the translation.

Chickenpox VIS

|

Up-to-date English-language [3/13/08]

• Information was added about MMRV vaccine, tied to the March 14 MMWR, regarding increased risk of certain adverse events, including febrile seizures, with MMRV when compared with MMR and varicella vaccines given separately. Aside from two boxes containing information about MMRV, both VISs are identical to the previous editions.
• The new VISs should be used when MMRV is given; but the existing stocks of the individual MMR and varicella VISs may be used when the vaccines are given separately.

MMR VIS

|

Up-to-date English-language [3/13/08]

• Information was added about MMRV vaccine, tied to the March 14 MMWR, regarding increased risk of certain adverse events, including febrile seizures, with MMRV when compared with MMR and varicella vaccines given separately. Aside from two boxes containing information about MMRV, both VISs are identical to the previous editions.
• The new VISs should be used when MMRV is given; but the existing stocks of the individual MMR and varicella VISs may be used when the vaccines are given separately.

DTaP VIS [7/30/01]

|

Up-to-date English-language [5/17/07]

• These translations do not contain the following CDC updates
• The main change is in Section 4, which now mentions Tdap.
• The NVICP and VAERS web addresses have also been updated
• The mortality rate for tetanus in Section 1 changed from 1 out of 10, to 2 out of 10 cases.
• The date changed to 5/17/07.

Hepatitis B VIS

|

Up-to-date English-language [7/18/07]

• On July 18, the CDC posted an interim VIS for hepatitis B. There are minor changes throughout, but the main purpose of the update is to emphasize the birth dose for all children.
• A final version will be developed.

Meningococcal VIS [10/07/05]

|

Up-to-date English-language [8/16/07]

• The meningococcal VIS has been updated slightly to incorporate ACIP's new recommendation to vaccinate all children & adolescents 11-18 years of age. The new VIS is dated (8/16/07); the change affects only the first 2 paragraphs of Section 3. In the VIS News link on the CDC website they say that providers needn't discard existing stocks of the previous edition, but should be prepared to explain the updated recommendation to their patients if they use the older version.
• The Guillain-Barre Syndrome (second bullet just above section 6) was changed slightly: "a few" was replaced by "some" to reflect the additional cases that were reported.

Tdap VIS [5/31/06]

|

Up-to-date English-language [7/012/06]

• CDC added more information about Tdap vaccine for adults.
• There are minor changes in Section 3 reflecting the ACIP's evolving recommendations regarding use of Tdap vaccine during pregnancy.

This page was updated on March 13, 2008